Filter
201
Filtered Results: 201
Text search:
monoclonal
antibodies
Featured
Recommendations
33
New Publications
36
Language
Document type
No document type
81
Guidelines
56
Studies & Reports
23
Manuals
15
Fact sheets
11
Strategic & Response Plan
7
Resource Platforms
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
India
15
Global
8
South Africa
6
Latin America and the Carribbean
5
Germany
5
Syria
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Nigeria
2
Niger
2
Afghanistan
2
Africa
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
Russia
2
Mali
2
Indonesia
2
Pakistan
2
North Macedonia
1
Colombia
1
Mexico
1
Ukraine
1
El Salvador
1
Turkey
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Chile
1
Cameroon
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
USA
1
Haiti
1
Dominican Republic
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Nicaragua
1
Brazil
1
Namibia
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
24
COVID-19
17
Vaccine-preventable Diseases
8
Drugs & Medical Equipment
6
Disease Prevention & Control
6
Virology
5
Rabies
4
Pediatrics
3
Policies & Guidelines HIV & TB
3
NTDs & Others
3
Non-communicable Diseases
3
Paediatrics
2
General Guidelines
2
Cancer Treatment & Resources
2
NCD
2
Hemorrhagic Fever
2
Diarrhoeal Disease/Cholera
2
Women & Child Health
2
Studies & Reports
2
Respiratory Infections
2
Immunization
2
Parasitology
2
Malaria
2
TB
2
Communicable Diseases
1
Clinical Training
1
Hepatitis
1
Public Health
1
Disaster Preparedness
1
Bacteriology
1
Cancer
1
Vector Control
1
Palliative Care
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Countries
1
Yellow Fever
1
Policies
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Humanitarian Crisis
1
Statistics
1
COPD/Asthma
1
Gynaecology & Obstetrics
1
Leishmaniasis
1
Laboratory Technologies
1
HIV & STI
1
Age & Elderly
1
Toolboxes
Clinical Guidelines
17
SARS-CoV-2 Variants
9
Inactivated COVID-19 Vaccines
7
Laboratory
6
Surveillance & Contact tracing
6
Genomic sequencing
6
Testing Guidelines
6
Surveillance
5
Public Health
5
Treatment Guidelines
5
Essential Medicines & Devices Lists
5
Laboratory Guidance
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Outbreak Prevention & Control
3
Clinical Aspects, Treatment & Prevention
3
Influenza Prevention & Control
3
Research
3
Prevention & Preparedness
3
Clinical Aspects
3
Diagnostics & Laboratory Guidance
3
Country specific documents
3
Scientific & Research Studies
3
Covaxin
3
Clinical Aspects & Diagnostics
3
Disease Prevention & Control
3
Preparedness & Prevention
3
Ebola Prevention & Control
2
Influenza
2
Vaccination
2
Essential List
2
Training, others
2
Appeals and Response Plans
2
Global Impact: Socio-economic, health services, TB & HIV
2
Essential Medicines & Medical Devices
2
Fair Allocation & Ethical Aspects
2
COVAX Initiative
2
Moderna
2
Biontech/Pfizer Comirnaty
2
Infectious Diseases
2
MPOX - Monkeypox
2
Health Financing Toolbox
2
Alzheimer's Disease & Dementia
2
Antiretroviral Treatment ART
2
Meningitis & Encephalitis
2
Drugs
1
ART Drug Resistance
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Guidelines
1
Country specific
1
Key Resources
1
Children & Adolescents
1
Plague
1
Drug resistance
1
Cholera Prevention & Control
1
Latin America
1
Ebola & Marburg
1
Ebola
1
Public Health
1
International
1
Climate & Health
1
Context & Facts
1
Situation Reports & Updates
1
Research & Development
1
Studies
1
Public Health
1
Risk Communication & Community Engagement
1
For General Public & Community
1
For Health Worker
1
Oxygen Therapy
1
Situation Reports COVID-19
1
Access & Strategy
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Presentation
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Quality Assurance
1
General documents One Health
1
Guidelines & Manuals
1
Zoonoses
1
Health Impact & Climate Change
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Access to treatment and laboratory
1
General Information & Methodology
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Prevention & Strategies
1
Clinical Guidelines
1
Neurological Disorders
1
Zika
1
Diarrhoea
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Clinical Guidelines
1
Laboratory
1
Context & Facts
1
Chikungunya
1
Laboratory & Diagnostics
1
Action Plans, Policies & Response
1
AMR
1
Public Health
1
Plague Prevention & Control
1
Training module on malaria control
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
Version 4
The purpose of these standard operating procedures (SOPs) is to offer policy guidance and to provide performance standards on how to respond to any type of poliovirus outbreak or event in a timely and effective manner, and specifically, to stop an outbrea...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Weekly epidemiological update on COVID-19, 28 September 2022
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
Each year more than one million women are diagnosed with breast cancer worldwide over half of whom will die from the disease. Breast cancer is the most common cancer and the leading cause of cancer death for women
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
